The page is the record's research on the issuer — no analyst, no rating, no view.

# Rakovina Therapeutics Inc. (TSXV: RKV) — research page

As of 2026-11-06 · ca-cm-kg · record version 1

## Identity and listing

The issuer is Rakovina Therapeutics Inc., listed on the TSXV under ticker RKV, with LEI 254900O0YVEUNI9UM016. The ISIN is not on the record. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is British Columbia (CA-BC). The issuer is listed and not halted.

## The disclosure read

The record holds 28 filings in the twelve months to 2026-11-06, across 24 filing days. The filings are 21 newswire releases, 4 exchange bulletins and 3 financial statements. The median gap between filing days is 12 days. The latest filing is a newswire release dated 2026-11-05, 1 day before the record date. The TSXV median cadence gap is 19 days, and the TSXV median latency is 17.0 days. The Life Sciences sector median cadence gap is 17.5 days, and the sector median latency is 14 days. The TSXV median filings count is 9, and the sector median filings count is 7.0.

## Auditor

The auditor of record is Davidson & Company LLP. The auditor's location is not on the record. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting, name change, domicile change or segment move events. The issuer is listed and not halted.

## Orderability

Under rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, chapter as of 2026-11-04, both client categories return signal ACM-200 and the outcome is determinable: Paragraph (o) of the definition and Paragraph (q) of the definition.

## Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

## Open research

No openly published research notes were found. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The vintage of this market is not sealed. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)
- https://api.gleif.org/api/v1/lei-records/254900O0YVEUNI9UM016 (identity.jurisdiction)
- https://www.tsx.com/en/resource/571 (identity.sector)
- https://mcp.ca-cm-kg.ai/events/TSXV/RKV (the disclosure lines)
- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
- https://www.biospace.com/press-releases/rakovina-therapeutics-announces-q2-2026-financial-results-and-provides-corporate-update (the auditor)
- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.ca-cm-kg.ai/record/TSXV/RKV (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/ca/TSXV/RKV · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
